Join us as we speak to Dr. Hongtao Liu and Dr. Adam DuVall from University of Chicago Medicine, about current and emerging cellular therapies for acute leukemias. These innovative therapies include CAR T-cell therapy, modified Natural Killer (NK) cells and stem cell transplantations. In this episode, we discuss how these groundbreaking therapies have changed the landscape of treatment for acute leukemias. The doctors share what they are excited about in the future, citing how clinical trials are advancing therapies and how cancer centers can better serve the unique needs of adolescent and young adults (AYAs) with acute leukemias by utilizing a holistic and comprehensive approach.

Mentioned on this episode: 

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• CAR T-cell Therapy
• Stem Cell Transplant
• Cellular Therapies
• Minimal/Measurable Residual Disease (MRD)
• Graft-Vs-Host Disease
• Adolescent and Young Adult (AYA) Oncology Program at University of Chicago
• CALMM Clinic at University of Chicago
• Young Adult Resources
• Survivorship Workbook
• Between Two Kingdoms

Additional LLS Support Resources: 

• Information Specialists 
• Free telephone/web patient programs 
• Free booklets 
• Financial support
• Clinical Trial Support Center
• Online chats 
• Caregiver support 
• LLS Community 
• Support groups 
• Patti Robinson Kaufmann First Connection Program 
• Free Nutrition Consultations

Support for this episode is provided by University of Chicago Medicine.

The post Innovative Therapies for Acute Leukemias appeared first on The Bloodline with LLS.